iThemba, which means 'hope' in Zulu, is a research based drug discovery company based in Modderfontein, South Africa. The company mission is to champion world-class, drug discovery and development activities to address unmet medical needs in the area of infectious diseases including HIV/Aids, Malaria and Tuberculosis (TB).
The company has developed a strong foundation in synthetic organic, natural product and medicinal chemistry; it has core staff with diverse multinational experience and is well-supported through several world renowned pharmaceutical experts, who sit on its scientific advisory and Director Boards.
iThemba received start-up funds from the South African Technology Innovation Agency (TIA).